Results 101 to 110 of about 338 (112)
Some of the next articles are maybe not open access.

Neoehrlichiosis associated with ocrelizumab in a patient with multiple sclerosis: A case report

Multiple Sclerosis Journal
Objective: To describe a case of neoehrlichiosis, an emerging opportunistic tick-borne infection, in a patient with multiple sclerosis (MS) treated with ocrelizumab. Methods: This is a case study. Results: Our patient developed clinical infection over several months while on ocrelizumab and was ultimately diagnosed with neoehrlichiosis, caused by the ...
Majid Afzal, Jeppe Romme Christensen
exaly   +3 more sources

[Neoehrlichiosis has entered the Stockholm region].

Lakartidningen, 2023
The number of cases diagnosed with neoehrlichiosis in Stockholm has increased over the last years. PCR analysis is needed for the detection of the intracellular bacterium Neoehrlichia mikurensis. The real number of cases in the area is unknown since the specific PCR for N mikurensis is not routinely included in the workup for unknown fever in Stockholm.
Hedvig, Glans   +2 more
openaire   +1 more source

[Neoehrlichiosis as a cause of feaver of unknown origin].

Zeitschrift fur Rheumatologie, 2022
Establishing a diagnosis in cases of fever of unknown origin (FUO) in immunocompromised patients can be difficult. In 25-35% infectious diseases are the underlying cause. This article reports the case of a 74-year-old woman with a 5-month history of fever.
Bernhard, Dumoulin   +5 more
openaire   +1 more source

Neoehrlichiosis in patients with multiple sclerosis in Halmstad, Sweden: A case series

open access: yesJournal of Neuroimmunology
Elias Ditlevsen Regen   +2 more
exaly   +2 more sources

Dual detection of Neoehrlichia mikurensis and Anaplasma phagocytophilum: How biplex PCR led in France to the diagnosis of neoehrlichiosis in post-tick bite fever

open access: yesInfectious Diseases Now
Neoehrlichia mikurensis (NM) is an emerging intracellular bacterium member of the Anaplasmatacecae family. So far, only four cases have been described in France, all of them retrospectively.This study describes two new cases of NM discovered following implementation of a biplex PCR targeting both Anaplasma and NM.Two immunocompetent patients developed ...
Benoît Jaulhac
exaly   +3 more sources

[Fever of unknown origin in a multiple sclerosis patient on immunomodulatory therapy was due to neoehrlichiosis].

Lakartidningen, 2017
Fever of unknown origin in a multiple sclerosis patient on immunomodulatory therapy was due to neoehrlichiosis The emerging tick-borne bacterium Candidatus Neoehrlichia mikurensis is the etiologic agent of neoehrlichiosis, a febrile illness that may be accompanied by vascular complications.
Arya, Dadgar   +3 more
openaire   +1 more source

[Neoehrlichiosis : rare tick-borne disease, also present in Switzerland].

Revue medicale suisse
For several years, there has been increasing awareness of a novel tick-borne infection within our region: neoehrlichiosis. The causative agent, Neoehrlichia mikurensis , is an intracellular bacterium classified within the Anaplasmataceae family. Predominantly afflicting immunosuppressed individuals, its clinical presentation often involves persistent ...
Pauline, Hämmerli   +5 more
openaire   +1 more source

Comparative Genomics of Clinical Isolates of the Emerging Tick-Borne Pathogen Neoehrlichia mikurensis

Microorganisms, 2021
Daniel Jaén-Luchoro   +2 more
exaly  

Infections with the tick-borne bacterium Candidatus Neoehrlichia mikurensis

Clinical Microbiology and Infection, 2015
Christine Wennerås
exaly  

Home - About - Disclaimer - Privacy